ASCRINVACUMAB
UNII 716FQ5REVO

Substance Identification & Data

This profile provides standardized clinical and technical data for Ascrinvacumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 716FQ5REVO.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1463459-96-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

716FQ5REVO

CAS Registry Number

1463459-96-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ASCRINVACUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C91073

National Cancer Institute reference terminology for clinical and research data.

INN ID

10106

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

BC-56

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ascrinvacumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ASCRINVACUMAB

Common Names & Synonyms

ASCRINVACUMAB [INN]

ASCRINVACUMAB [USAN]

ASCRINVACUMAB [WHO-DD]

IMMUNOGLOBULIN G2, ANTI-(HUMAN ACTIVIN RECEPTOR-LIKE KINASE 1) (HUMAN MONOCLONAL PF-03446962 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PF-03446962 LIGHT CHAIN, DIMER